Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 124-65-2
Product Catalog
11-1000
Sodium › Sodium cacodylate hydrate, 98%| CAS Number: | 124-65-2 |
| MDL Number: | MFCD00149078 |
| Molecular Formula: | C2H6AsNaO2 |
| Molecular Weight: | 159.91 |
| Chemical Formula: | (CH3)2As(O)ONa·XH2O |
| Color and Form: | white pwdr. |
| Note: |
Safety: Hazardous
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Sodium cacodylate hydrate, 98% |
| Product Number: | 11-1000 |
| CAS Registry Number: | 124-65-2 |
| Formula: | (CH3)2As(O)ONa.XH2O |
| EINECS Number: | 204-708-2 |
| Chemical Family: | inorganic compound |
| Synonym: | Arsenic acid, dimethyl-, sodium salt, Sodium, dimethylarsinate |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title compound | 124-65-2 | 100 | 0.01mg/m3 (as As) | 0.5 mg/m3 (as As) |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Toxic by inhalation and if swallowed. Symptoms include burning in the throat, colicky pains in the stomach, garlicky odor of the breath, shortness of breath with pain in the chest, nausea and diarrhea. Possible risk of irreversible effects. |
| Primary Routes of Exposure: | Inhalation, Ingestion, skin |
| Eye Contact: | May cause severe irritation of the eyes. |
| Skin Contact: | May cause irritation of the skin, ulceration, spotty pigmentation, dermatitis and skin cancer.. |
| Inhalation: | May be severely irritating to the nose and respiratory tract. May induce perforation of the nasal septum and cause arsenic poisoning |
| Ingestion: | Ingestion may lead to nausea, vomiting, bloody diarrhea, weakness, low blood pressure, shock, coma and death. |
| Acute Health Effects: | Salty taste, burning in the throat, colicky pains in the stomach and intestines, and garlicky odor of the breath, urine, and sweat. In persons exposed to sufficient arsenical dust, the onset of illness is usually characterized by difficult or short breath with pain in the chest, followed by nausea and diarrhea. |
| Chronic Health Effects: | Blanching or flushing of the skin (especially of the fingers), cirrhosis of the liver, atrophy of the bone marrow, kidney damage, and loss of sensory and motor functions have been reported. About 6 weeks after exposure to cacodylic acid, white bands may appear across the toe and finger nails. Possible risk of irreversible effects. |
| NTP: | Yes |
| IARC: | Yes |
| OSHA: | Yes |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area immediately with water. Remove contaminated clothing if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | no data |
| Autoignition Temperature: | no data |
| Explosion Limits: | no data |
| Extinguishing Medium: | carbon dioxide or dry powder or foam |
| Special Fire Fighting Procedures: | If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure self- contained breathing apparatus and full protective clothing. |
| Hazardous Combustion and Decomposion Products: | If involved in a fire, this material may emit toxic and corrosive fumes. |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazard. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | Sweep up the solid and dispose of properly. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store the material in a tightly sealed container. Keep away from heat. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Handle the material in an efficient fume hood. |
| Respirator: | If ventilation is not available a respirator should be worn. The use of respirators requires a Respiratory Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | crystal |
| Molecular Weight: | 159.91 |
| Melting Point: | no data |
| Boiling Point: | no data |
| Vapor Pressure: | 1mm (372°C) |
| Specific Gravity: | no data |
| Odor: | not determined |
| Solubility in Water: | insoluble |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | air and moisture stable |
| Hazardous Polymerization: | No hazardous polymerization |
| Conditions to Avoid: | none |
| Incompatibility: | strong reducing agents |
| Decomposition Products: | organoarsenic vapors |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Oral (rat); LD50: 2600 mg/kg. Oral (mouse); LD50: 4gm/kg. Intraperitoneal (mouse); LD50: >1 gm/kg. Intraperitoneal (hamster); TDLo: 900 mg/kg. Intraperitoneal (hamster); TDLo: 900 mg/kg. Mouse Lymphocyte; Mutation in mammalian somatic cells: 9 gm/L. |
| Carcinogenic Effects: | no data |
| Mutagenic Effects: | Possible mutagen |
| Tetratogenic Effects: | Insufficient data |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | Avoid release into the environment. Very toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Sodium cacodylate |
| Hazard Class (CFR): | 6.1 |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | II |
| UN ID Number (CFR): | UN# 1688 |
| Shipping Name (IATA): | Sodium cacodylate |
| Hazard Class (IATA): | 6.1 |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | II |
| UN ID Number (IATA): | UN# 1688 |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory. |
| SARA (Title 313): | Title compound not regulated under Sec. 313. |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 7/01/2004 |
| Revision Date: | 12/19/2011 |
